Profil
Florian Hauer was the founder of Labforward GmbH, founded in 2012, where the title held was Chief Operating Officer.
Dr. Hauer is the founder of Myimmune Corp., founded in 2024, holding the title of Chief Executive Officer.
Dr. Hauer currently works at KEPLER-FONDS Kapitalanlagegesellschaft m.b.H.
as an Equity Fund Manager since 2023.
Postes actifs de Florian Hauer
| Sociétés | Poste | Début |
|---|---|---|
KEPLER-FONDS Kapitalanlagegesellschaft m.b.H.
KEPLER-FONDS Kapitalanlagegesellschaft m.b.H. Investment ManagersFinance KEPLER-FONDS KAG’s common investment strategies are covered by the value-oriented, mixed and growth-oriented in the corresponding fund products. Core competencies in risk-averse management approaches are implemented in large-, mid- and small-caps. The investment universe includes not only the traditional industrialized nations but also emerging markets. Even small-volume issues with attractive interest premiums are considered when selecting securities. | Gestionnaire de Portefeuille-Actions | 01/01/2010 |
Anciens postes connus de Florian Hauer
| Sociétés | Poste | Fin |
|---|---|---|
Labforward GmbH
Labforward GmbH Information Technology ServicesTechnology Services Engages in transformation of laboratories into intelligent workspaces with smart digital solutions | Fondateur | 01/12/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
KEPLER-FONDS Kapitalanlagegesellschaft m.b.H.
KEPLER-FONDS Kapitalanlagegesellschaft m.b.H. Investment ManagersFinance KEPLER-FONDS KAG’s common investment strategies are covered by the value-oriented, mixed and growth-oriented in the corresponding fund products. Core competencies in risk-averse management approaches are implemented in large-, mid- and small-caps. The investment universe includes not only the traditional industrialized nations but also emerging markets. Even small-volume issues with attractive interest premiums are considered when selecting securities. | Finance |
Labforward GmbH
Labforward GmbH Information Technology ServicesTechnology Services Engages in transformation of laboratories into intelligent workspaces with smart digital solutions | Technology Services |
















